GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK)
NEW YORK (
) -- The ex-dividend date for
(NYSE:
) is tomorrow, February 15, 2012. Owners of shares as of market close today will be eligible for a dividend of 82 cents per share. At a price of $45.31 as of 9:30 a.m. ET, the dividend yield is 5%.
The average volume for GlaxoSmithKline has been 2.5 million shares per day over the past 30 days. GlaxoSmithKline has a market cap of $112.52 billion and is part of the
sector and
industry. Shares are down 0.4% year to date as of the close of trading on Monday.
GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. The company has a P/E ratio of 45.2, above the average drugs industry P/E ratio of 17.9 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates GlaxoSmithKline as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company has had generally poor debt management on most measures that we evaluated. You can view the full
GlaxoSmithKline Ratings Report
.
See our
or
.
null
